Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Lake Bioscience CoSHSE:600866 +1.60%67 Interest Coverage is 8.69 as of Jun. 2026, which is 31% below its 10-year median of 12.56. GuruFocus rates SHSE:600866 with a GF Score™ of 67/100 and a GF Value™ of ¥5.89 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 373 Biotechnology companies, Star Lake Bioscience Co ranks worse than 83.11% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Star Lake Bioscience Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥217 Mil. Star Lake Bioscience Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥-25 Mil.
Star Lake Bioscience Co's interest coverage for the quarter that ended in Jun. 2026 was 8.69.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Star Lake Bioscience Co's Interest Coverage or its related term are showing as below:
SHSE:600866'
s Interest Coverage Range Over the Past 10 Years
Min: 0.39 Med: 12.56 Max: 22.37
Current: 5.57
SHSE:600866's Interest Coverage is ranked worse than 83.11% of 373
companies
in the Biotechnology industry
Industry Median: 106.14
vs SHSE:600866: 5.57
Star Lake Bioscience Co (SHSE:600866) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Star Lake Bioscience Co Interest Coverage Related Terms
Star Lake Bioscience Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Star Lake Bioscience Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SHSE:600866 vs VRTX, REGN, MRNA: Interest Coverage Comparison
For the Biotechnology subindustry, Star Lake Bioscience Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Lake Bioscience Co Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Star Lake Bioscience Co's Interest Coverage falls into.
Star Lake Bioscience Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Lake Bioscience Co (SHSE:600866) has a Interest Coverage of 8.69 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Star Lake Bioscience Co and its competitors. This is 31% below median its historical median of 12.56. Over the past decade, Star Lake Bioscience Co's Interest Coverage has ranged from 0.39 to 22.37. According to the industry distribution chart, Star Lake Bioscience Co ranks #310 out of 373 companies in the Biotechnology industry, placing it in the top 83.1%.
Is Star Lake Bioscience Co's Interest Coverage too high?
Star Lake Bioscience Co's current Interest Coverage of 8.69 is 31% below median its 10-year median of 12.56. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 22.37. The Biotechnology industry median Interest Coverage is 106.14. Star Lake Bioscience Co's value of 8.69 is 91.8% below this industry median. Based on the distribution chart, Star Lake Bioscience Co ranks #310 out of 373 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Star Lake Bioscience Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Star Lake Bioscience Co's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Star Lake Bioscience Co ranks #310 out of 373 companies for Interest Coverage. This places Star Lake Bioscience Co in the lower half of its industry. The industry median Interest Coverage is 106.14. Star Lake Bioscience Co's value of 8.69 is 91.8% below this benchmark. Historically, Star Lake Bioscience Co's own Interest Coverage has ranged from 0.39 to 22.37 over the past decade. While the company's 10-year median is 12.56 vs. the industry median of 106.14, Star Lake Bioscience Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.14, based on 373 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Lake Bioscience Co's current Interest Coverage of 8.69 is 91.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Star Lake Bioscience Co and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Lake Bioscience Co's current Interest Coverage is 8.69, which is 31% below median its own 10-year median of 12.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Lake Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Star Lake Bioscience Co (SHSE:600866) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.89, compared to a current price of ¥4.45 — trading 24.4% below its estimated fair value. The current Interest Coverage is 8.69, which is 31% below median its 10-year median of 12.56 and 91.8% below the Biotechnology industry median of 106.14. Star Lake Bioscience Co's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Star Lake Bioscience Co (SHSE:600866), the current Interest Coverage is 8.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?
Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued.
The current stock price of ¥4.45 is trading 24.4% below its estimated GF Value™ of ¥5.89.
GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.
Key valuation signals for SHSE:600866:
Interest Coverage: 8.69 (31% below median its 10-year median of 12.56)
GF Value™: ¥5.89 vs. price of ¥4.45 (24.4% below fair value)
Industry Position: 91.8% below the Biotechnology median (#310 of 373)
No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
67GF Score
Get the complete analysis for SHSE:600866
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600866 has been successfully added to your 
